lung cancer

Pfizer's Lorbrena makes play for earlier lung cancer use with Xalkori-topping data
Fierce Pharma
Wed, 08/5/20 - 11:22 pm
Pfizer
Lorbrena
lung cancer
Xalkori
clinical trials
A turn-up for Spectrum’s book
EP Vantage
Tue, 07/28/20 - 10:32 am
poziotinib
Spectrum Pharmaceuticals
lung cancer
Takeda
Lung cancer study IDs new 'epigenomic' target for diagnosis and treatment
Fierce Biotech
Fri, 07/24/20 - 09:32 am
Harvard
MIT
epigenomics
cancer
lung cancer
diagnostics
In pilot of patient-reported outcomes project, FDA hopes to encourage ‘more rigorous’ data collection
MedCity News
Sun, 06/28/20 - 06:56 pm
AstraZeneca
clinical trials
Tagrisso
FDA
lung cancer
patients
ASCO data back AZ/Daiichi Sankyo’s Enhertu in new HER2 cancers
Pharmaforum
Sat, 05/30/20 - 08:04 pm
Daiichi Sankyo
AstraZeneca
Enhertu
stomach cancer
colorectal cancer
lung cancer
ASCO 2020
AstraZeneca's Blockbuster Lung Cancer Drug Has a Huge Sales Boost Ahead
Motley Fool
Sat, 05/30/20 - 07:48 pm
AstraZeneca
ASCO 2020
lung cancer
adjuvants
Tagrisso
AstraZeneca bid to expand lung cancer drug's use boosted by trial data
BioPharma Dive
Thu, 05/28/20 - 11:12 pm
AstraZeneca
Tagrisso
lung cancer
clinical trials
ASCO 2020
3 Roche Companies Hope to Make Clinical Trials More Efficient
Medical Devices and Diagnostics Industry
Tue, 05/19/20 - 11:19 pm
Flatiron Health
Foundation Medicine
Genentech
Roche
genomics
clinical trials
lung cancer
AstraZeneca to unveil key data for cancer drugs at ASCO
Pharmaforum
Fri, 05/15/20 - 10:41 am
AstraZeneca
ASCO 2020
Tagrisso
lung cancer
Enhertu
breast cancer
gastric cancer
colorectal cancer
ASCO 2020 – first-line lung cancer focus
EP Vantage
Thu, 05/14/20 - 12:02 pm
Roche
Merck
Bristol-Myers Squibb
ASCO 2020
lung cancer
Keytruda
tiragolumab
Opdivo
Yervoy
Go or no go? Oncology dominates upcoming decisions
EP Vantage
Fri, 05/1/20 - 11:09 am
FDA
oncology
AstraZeneca
Lynparza
ovarian cancer
prostate cancer
Bristol-Myers Squibb
Opdivo
lung cancer
#AACR20: Early data suggest Novartis' Incyte-discovered MET inhibitor helps lung cancer patients with brain lesions
Endpoints
Mon, 04/27/20 - 09:43 am
Novartis
Incyte
AACR
lung cancer
MET inhibitors
capmatinib
Lantern files for IPO to study 5-time phase 3 cancer failure
Fierce Biotech
Fri, 04/17/20 - 10:47 am
Lantern Pharma
IPOs
LP-300
lung cancer
BeiGene reports positive Phase III interim analysis for lung cancer drug
MedCity News
Wed, 04/15/20 - 10:41 am
BeiGene
clinical trials
immunotherapy
lung cancer
tislelizumab
non-squamous non-small cell lung cancer
AstraZeneca's Imfinzi gets FDA nod to target small-cell lung cancer
Reuters
Mon, 03/30/20 - 10:49 am
AstraZeneca
FDA
Imfinzi
lung cancer
Small-Cell Lung Cancer
First of its Kind “Universal” Immune Cell Cancer Therapy
Xtalks
Thu, 01/23/20 - 12:18 pm
cancer
immune system
prostate cancer
lung cancer
breast cancer
Cardiff University
BeiGene lung cancer treatment meets main goal in late-stage study
Reuters
Tue, 01/21/20 - 11:53 am
BeiGene
cancer
lung cancer
clinical trials
tislelizumab
The three biggest challenges in lung cancer, and how researchers are tackling them
Pharmaforum
Tue, 01/21/20 - 11:02 am
lung cancer
Lung Ambition Alliance
R&D
Bankrupt uBiome sells off patents, data for $7M; J&J buys options on Pulmatrix's lung cancer drugs
Endpoints
Fri, 01/3/20 - 10:08 am
uBiome
microbiome
M&A
Psomagen
JNJ
Pulmatrix
lung cancer
Spectrum Pharma Shares Slump After Lung-Cancer Drug Doesn't Meet Phase II Endpoint
TheStreet.com
Thu, 12/26/19 - 01:16 pm
Spectrum Pharma
lung cancer
clinical trials
poziotinib
non-small cell lung cancer

Pages